The concept of leukaemic stem cells in acute myeloid leukaemia 25 years on: hitting a moving target

British Journal of Haematology
Peter HoklandMarie Bill

Abstract

The concept of leukaemic stem cells (LSCs) was experimentally suggested 25 years ago through seminal data from John Dick's group, who showed that a small fraction of cells from acute myeloid leukaemia (AML) patients were able to be adoptively transferred into immunodeficient mice. The initial estimation of the frequency was 1:250 000 leukaemic cells, clearly indicating the difficulties ahead in translating knowledge on LSCs to the clinical setting. However, the field has steadily grown in interest, expanse and importance, concomitantly with the realisation of the molecular background for AML culminating in the sequencing of hundreds of AML genomes. The literature is now ripe with contributions describing how different molecular aberrations are more or less specific for LSCs, as well as reports showing selectivity in targeting LSCs in comparison to normal haematopoietic stem and progenitor cells. However, we argue here that these important data have not yet been fully realised within the clinical setting. In this clinically focused review, we outline the difficulties in identifying and defining LSCs at the individual patient level, with special emphasis on intraclonal heterogeneity. In addition, we suggest areas of future focus ...Continue Reading

References

Oct 1, 1976·Science·P C Nowell
May 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·H J SutherlandC J Eaves
Apr 25, 2009·British Journal of Haematology·Véronique Gelsi-BoyerDaniel Birnbaum
Aug 7, 2009·The New England Journal of Medicine·Elaine R MardisTimothy J Ley
Dec 24, 2010·JAMA : the Journal of the American Medical Association·Andrew J GentlesAsh A Alizadeh
Nov 15, 2011·Nature Biotechnology·Piero DalerbaStephen R Quake
Jan 31, 2012·Blood·Roland B WalterIrwin D Bernstein
Oct 12, 2012·Nature Reviews. Cancer·Peter ValentConnie Eaves
May 3, 2013·The New England Journal of Medicine·UNKNOWN Cancer Genome Atlas Research NetworkGreg Eley
Mar 13, 2014·Cell Stem Cell·Antonija Kreso, John E Dick
Feb 12, 2015·Leukemia·H Mora-JensenK Theilgaard-Mönch
Jun 25, 2015·British Journal of Haematology·Wendelien ZeijlemakerGerrit J Schuurhuis
Jan 26, 2016·Nature Reviews. Genetics·Charles GawadStephen R Quake
Aug 11, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas B AlexanderJeffrey E Rubnitz
Aug 30, 2016·Cell Stem Cell·Leslie A CrewsCatriona H M Jamieson
Jan 10, 2017·The Journal of Clinical Investigation·Ander AbarrategiDominique Bonnet
Feb 6, 2017·Blood·Daniel A Pollyea, Craig T Jordan

❮ Previous
Next ❯

Citations

Jun 3, 2021·International Journal of Molecular Sciences·Jan Jakub LicaAndrzej Składanowski

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.

Related Papers

British Journal of Haematology
Alfonso E Bencomo-AlvarezAnna M Eiring
British Journal of Haematology
Ming-Che OuChieh-Lin Teng
© 2021 Meta ULC. All rights reserved